HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+5.08%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$126M
AUM Growth
+$126M
(-17%)
Cap. Flow
-$6.62M
Cap. Flow
% of AUM
-5.27%
Top 10 Holdings %
Top 10 Hldgs %
47.53%
Holding
143
New
16
Increased
24
Reduced
10
Closed
74
Top Buys
| 1 |
COHR
Coherent Inc
COHR
|
$3.63M |
| 2 |
PBCT
People's United Financial Inc
PBCT
|
$3.5M |
| 3 |
CONE
CyrusOne Inc Common Stock
CONE
|
$3.47M |
| 4 |
Merus
MRUS
|
$1.71M |
| 5 |
Cytokinetics
CYTK
|
$1.61M |
Top Sells
| 1 |
Dell
DELL
|
$19.4M |
| 2 |
PPD
PPD, Inc. Common Stock
PPD
|
$3.51M |
| 3 |
KSU
Kansas City Southern
KSU
|
$3.49M |
| 4 |
iShares MSCI India Small-Cap ETF
SMIN
|
$3.15M |
| 5 |
FIVE9
FIVN
|
$2.78M |
Sector Composition
| 1 | Healthcare | 52.52% |
| 2 | Technology | 21.51% |
| 3 | Consumer Discretionary | 5.99% |
| 4 | Communication Services | 3.46% |
| 5 | Financials | 2.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Prothena Corp
PRTA
$452M
| $1.39M | 1.1% |
+28,078
| New | +$1.39M |
|
|
MRTX
27
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.36M | 1.08% |
9,236
+747
| +9% | +$110K |
|
28
United Therapeutics
UTHR
$17.7B
| $1.35M | 1.08% |
6,266
+362
| +6% | +$78.2K |
|
29
Fate Therapeutics
FATE
$115M
| $1.35M | 1.07% |
23,081
+5,947
| +35% | +$348K |
|
30
Amicus Therapeutics
FOLD
$2.42B
| $1.31M | 1.04% |
113,387
| – | – |
|
31
Iovance Biotherapeutics
IOVA
$800M
| $1.27M | 1.01% |
66,639
+10,363
| +18% | +$198K |
|
|
HZNP
32
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.22M | 0.97% |
11,298
| – | – |
|
33
Alnylam Pharmaceuticals
ALNY
$58.6B
| $1.2M | 0.96% |
7,093
+935
| +15% | +$159K |
|
34
Celldex Therapeutics
CLDX
$1.57B
| $1.15M | 0.92% |
29,856
+1,390
| +5% | +$53.7K |
|
35
Kura Oncology
KURA
$732M
| $1.15M | 0.92% |
82,124
+11,236
| +16% | +$157K |
|
36
Ascendis Pharma
ASND
$12.1B
| $1.15M | 0.91% |
8,541
-1,228
| -13% | -$165K |
|
37
Vertex Pharmaceuticals
VRTX
$102B
| $1.13M | 0.9% |
+5,135
| New | +$1.13M |
|
38
VistaGen Therapeutics
VTGN
$113M
| $1.13M | 0.9% |
577,031
+138,792
| +32% | +$271K |
|
|
MORF
39
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $1.13M | 0.9% |
23,751
+3,406
| +17% | +$161K |
|
|
SWTX
40
DELISTED
SpringWorks Therapeutics
SWTX
| $1.11M | 0.88% |
17,870
+2,276
| +15% | +$141K |
|
41
Beam Therapeutics
BEAM
$1.9B
| $1.08M | 0.86% |
13,538
+2,064
| +18% | +$165K |
|
42
Protagonist Therapeutics
PTGX
$3.62B
| $1.06M | 0.84% |
30,999
+2,688
| +9% | +$91.9K |
|
43
Avidity Biosciences
RNA
$6.12B
| $1.05M | 0.84% |
44,294
-12,558
| -22% | -$299K |
|
44
Natera
NTRA
$23B
| $1.03M | 0.82% |
11,039
| – | – |
|
45
Rocket Pharmaceuticals
RCKT
$358M
| $1.02M | 0.82% |
46,913
+6,242
| +15% | +$136K |
|
46
C4 Therapeutics
CCCC
$182M
| $1.01M | 0.81% |
31,493
+2,152
| +7% | +$69.3K |
|
|
WHWK
47
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
| $979K | 0.78% |
+40,549
| New | +$979K |
|
48
Instil Bio
TIL
$196M
| $974K | 0.78% |
56,901
-15,178
| -21% | -$260K |
|
49
Regenxbio
RGNX
$498M
| $973K | 0.77% |
+29,753
| New | +$973K |
|
50
IDEAYA Biosciences
IDYA
$2.26B
| $960K | 0.76% |
+40,619
| New | +$960K |
|